Related references
Note: Only part of the references are listed.PI3K Driver Mutations: A Biophysical Membrane-Centric Perspective
Mingzhen Zhang et al.
CANCER RESEARCH (2021)
RAF kinase dimerization: implications for drug discovery and clinical outcomes
Tilman Brummer et al.
ONCOGENE (2020)
Ras assemblies and signaling at the membrane
Ruth Nussinov et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2020)
SOS1 interacts with Grb2 through regions that induce closed nSH3 conformations
Tsung-Jen Liao et al.
JOURNAL OF CHEMICAL PHYSICS (2020)
Inhibitors of BRAF dimers using an allosteric site
Xiomaris M. Cotto-Rios et al.
NATURE COMMUNICATIONS (2020)
Identification and Characterization of a B-Raf Kinase α-Helix Critical for the Activity of MEK Kinase in MAPK Signaling
Diep Nguyen et al.
BIOCHEMISTRY (2020)
Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks
Magdalena Smiech et al.
GENES (2020)
The current understanding of KRAS protein structure and dynamics
Tatu Pantsar
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Defining a new nomenclature for the structures of active and inactive kinases
Vivek Modi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Design and Synthesis of Type-IV Inhibitors of BRAF Kinase That Block Dimerization and Overcome Paradoxical MEK/ERK Activation
Chad M. Beneker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Biochemical Characterization of Full-Length Oncogenic BRAFV600E together with Molecular Dynamics Simulations Provide Insight into the Activation and Inhibition Mechanisms of RAF Kinases
Nicholas Cope et al.
CHEMBIOCHEM (2019)
The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients
Quan Lin et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
The Structural Basis of the Farnesylated and Methylated KRas4B Interaction with Calmodulin
Hyunbum Jang et al.
STRUCTURE (2019)
Targeting Oncogenic BRAF: Past, Present, and Future
Aubhishek Zaman et al.
CANCERS (2019)
Ca2+-Dependent Switch of Calmodulin Interaction Mode with Tandem IQ Motifs in the Scaffolding Protein IQGAP1
Mingzhen Zhang et al.
BIOCHEMISTRY (2019)
Does Ras Activate Raf and PI3K Allosterically?
Ruth Nussinov et al.
FRONTIERS IN ONCOLOGY (2019)
The structural basis for Ras activation of PI3Kα lipid kinase
Mingzhen Zhang et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2019)
The mechanism of PI3K activation at the atomic level
Mingzhen Zhang et al.
CHEMICAL SCIENCE (2019)
Unraveling the molecular mechanism of interactions of the Rho GTPases Cdc42 and Rac1 with the scaffolding protein IQGAP2
E. Sila Ozdemir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDEδ
E. Sila Ozdemir et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2018)
SWISS-MODEL: homology modelling of protein structures and complexes
Andrew Waterhouse et al.
NUCLEIC ACIDS RESEARCH (2018)
The dimer-dependent catalytic activity of RAF family kinases is revealed through characterizing their oncogenic mutants
Jimin Yuan et al.
ONCOGENE (2018)
Raf-1 Cysteine-Rich Domain Increases the Affinity of K-Ras/Raf at the Membrane, Promoting MAPK Signaling
Shuai Li et al.
STRUCTURE (2018)
Molecular recognition of RAS/RAF complex at the membrane: Role of RAF cysteine-rich domain
Timothy Travers et al.
SCIENTIFIC REPORTS (2018)
Allosteric KRas4B Can Modulate SOS1 Fast and Slow Ras Activation Cycles
Tsung-Jen Liao et al.
BIOPHYSICAL JOURNAL (2018)
Allosteric activation of RAF in the MAPK signaling pathway
Chung-Jung Tsai et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2018)
Calmodulin (CaM) Activates PI3Kα by Targeting the Soft CaM-Binding Motifs in Both the nSH2 and cSH2 Domains of p85α
Mingzhen Zhang et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2018)
CHARMM36m: an improved force field for folded and intrinsically disordered proteins
Jing Huang et al.
NATURE METHODS (2017)
Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction
Hyunbum Jang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
PDEδ Binding to Ras Isoforms Provides a Route to Proper Membrane Localization
Serena Muratcioglu et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2017)
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
Zhan Yao et al.
NATURE (2017)
The dynamic mechanism of RASSF5 and MST kinase activation by Ras
Tsung-Jen Liao et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2017)
A dynamic hydrophobic core orchestrates allostery in protein kinases
Jonggul Kim et al.
SCIENCE ADVANCES (2017)
Phosphorylated Calmodulin Promotes PI3K Activation by Binding to the SH2 Domains
Mingzhen Zhang et al.
BIOPHYSICAL JOURNAL (2017)
Classifying kinase conformations using a machine learning approach
Daniel Ian McSkimming et al.
BMC BIOINFORMATICS (2017)
Discrete cytosolic macromolecular BRAF complexes exhibit distinct activities and composition
Britta Diedrich et al.
EMBO JOURNAL (2017)
Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view
Shaoyong Lu et al.
CHEMICAL SOCIETY REVIEWS (2016)
Comparison of the Conformations of KRAS Isoforms, K-Ras4A and K-Ras4B, Points to Similarities and Significant Differences
Mayukh Chakrabarti et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2016)
A Novel RAF Kinase Inhibitor with DFG-Out-Binding Mode: High Efficacy in BRAF-Mutant Tumor Xenograft Models in the Absence of Normal Tissue Hyperproliferation
Irene C. Waizenegger et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site
Tanmay S. Chavan et al.
BIOPHYSICAL JOURNAL (2015)
Inhibition of RAF lsoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers
Sheng-Bin Peng et al.
CANCER CELL (2015)
BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition
Zhan Yao et al.
CANCER CELL (2015)
Mechanisms of Membrane Binding of Small GTPase K-Ras4B Farnesylated Hypervariable Region
Hyunbum Jang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The Effect of a Widespread Cancer-Causing Mutation on the Inactive to Active Dynamics of the B-Raf Kinase
Kristen A. Marino et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
RAF inhibitors that evade paradoxical MAPK pathway activation
Chao Zhang et al.
NATURE (2015)
Regulation of RAF protein kinases in ERK signalling
Hugo Lavoie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Mechanism and consequences of RAF kinase activation by small-molecule inhibitors
M. Holderfield et al.
BRITISH JOURNAL OF CANCER (2014)
Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling
Jacob R. Haling et al.
CANCER CELL (2014)
Kinases and Pseudokinases: Lessons from RAF
Andrey S. Shaw et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer
Luping Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Matthew Holderfield et al.
NATURE REVIEWS CANCER (2014)
Allosteric Activation of Functionally Asymmetric RAF Kinase Dimers
Jiancheng Hu et al.
CELL (2013)
Effects of Raf Dimerization and Its Inhibition on Normal and Disease-Associated Raf Signaling
Alyson K. Freeman et al.
MOLECULAR CELL (2013)
Single-molecule superresolution imaging allows quantitative analysis of RAF multimer formation and signaling
Xiaolin Nan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Deciphering the Structural Basis of Eukaryotic Protein Kinase Regulation
Hiruy S. Meharena et al.
PLOS BIOLOGY (2013)
RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation
Madhurima Saha et al.
BIOCHEMICAL JOURNAL (2012)
Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling
Michael Roering et al.
EMBO JOURNAL (2012)
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Axel Hauschild et al.
LANCET (2012)
Evolution of the eukaryotic protein kinases as dynamic molecular switches
Susan S. Taylor et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I. Poulikakos et al.
NATURE (2011)
Update of the CHARMM All-Atom Additive Force Field for Lipids: Validation on Six Lipid Types
Jeffery B. Klauda et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2010)
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikos I. Poulikakos et al.
NATURE (2010)
CHARMM: The Biomolecular Simulation Program
B. R. Brooks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
A dimerization-dependent mechanism drives RAF catalytic activation
Thanashan Rajakulendran et al.
NATURE (2009)
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Stefan Pfister et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
James Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism
Alexandr P. Kornev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The amino-terminal B-Raf-specific region mediates calcium-dependent homo- and hetero-dimerization of Raf
Kenta Terai et al.
EMBO JOURNAL (2006)
V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors
OM Grbovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Scalable molecular dynamics with NAMD
JC Phillips et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
B-Raf and Raf-1 are regulated by distinct autoregulatory mechanisms
NH Tran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma
EE Patton et al.
CURRENT BIOLOGY (2005)
Regulation of raf-1 by direct feedback phosphorylation
MK Dougherty et al.
MOLECULAR CELL (2005)
Identification of novel ERK-mediated feedback phosphorylation sites at the C-terminus of B-Raf
T Brummer et al.
ONCOGENE (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Share Paper
